Substance P and somatostatin regulate sympathetic noradrenergic function

Science. 1983 Sep 9;221(4615):1059-61. doi: 10.1126/science.6192502.

Abstract

Peptidergic-noradrenergic interactions were examined in explants of rat sympathetic superior cervical ganglia and in cultures of dissociated cells. The putative peptide transmitters substance P and somatostatin each increased the activity of the catecholamine-synthesizing enzyme tyrosine hydroxylase after 1 week of exposure in culture. Maximal increases occurred at 10(-7) molar for each peptide, and either increasing or decreasing the concentration reduced the effects. Similar increases in tyrosine hydroxylase were produced by a metabolically stable agonist of substance P, while a substance P antagonist prevented the effects of the agonist. The data suggest that the increased tyrosine hydroxylase activity was mediated by peptide interaction with specific substance P receptors and that peptides may modulate sympathetic catecholaminergic function.

MeSH terms

  • Animals
  • Bacitracin / pharmacology
  • Captopril / pharmacology
  • Cells, Cultured
  • Culture Techniques
  • Dose-Response Relationship, Drug
  • Ganglia, Sympathetic / enzymology*
  • Rats
  • Somatostatin / pharmacology*
  • Substance P / pharmacology*
  • Tyrosine 3-Monooxygenase / metabolism*

Substances

  • Bacitracin
  • Substance P
  • Somatostatin
  • Captopril
  • Tyrosine 3-Monooxygenase